Company profile
Kymera Therapeutics
Inventing a new class of medicines using Targeted Protein Degradation
- Industry
- Biotechnology Research
- Employees
- 303
- Headquarters
- Watertown, MA
- Founded
- 2016
- LinkedIn followers
- 45,451
- Office locations
- 1
Kymera Therapeutics company summary
Kymera Therapeutics is a company in the Biotechnology Research industry, headquartered in Watertown, MA, founded in 2016. On LinkedIn the company has around 303 employees and 45,451 followers.
What technology does Kymera Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Kymera Therapeutics
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.
Where is Kymera Therapeutics located?
Kymera Therapeutics lists 1 location.
Compare companies similar to Kymera Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Kymera Therapeutics kymeratx.com | Biotechnology Research | 303 | 2016 | Watertown, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Kymera Therapeutics
What does Kymera Therapeutics do?
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.
How many employees does Kymera Therapeutics have?
Kymera Therapeutics has around 303 employees on LinkedIn.
Where is Kymera Therapeutics headquartered?
Kymera Therapeutics is headquartered in Watertown, MA.
When was Kymera Therapeutics founded?
Kymera Therapeutics was founded in 2016.
Build a lead list from companies like Kymera Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.